Skip to contents

This is information on the duration of CTN-0094 trial periods.

Usage

data(meta_study_length)

Format

A tibble with 16 rows and 6 variables:

project
Type:factor (First/Reference level = 27)
Description:CTN project number
Levels:27, 30, 51
treatment
Type:factor (First/Reference level = Inpatient BUP)
Description:
  • ctn_0027:
    • Methadone
    • Outpatient BUP
  • ctn_0030:
    • Outpatient BUP + EMM
    • Outpatient BUP + SMM
  • ctn_0051:
    • Outpatient BUP + EMM
    • Outpatient BUP + SMM
Levels:Inpatient BUP, Inpatient NR-NTX, Methadone, Outpatient BUP, Outpatient BUP + EMM, Outpatient BUP + SMM
phase
Type:factor (First/Reference level = 1)
Description:Study phase (needed because of CTN 30)
Levels:1, 2
stage
Type:factor (First/Reference level = 1)
Description:Treatment stage used with description to capture different treatment phase/stage/period
Levels:1, 2, 3
weeks
Type:integer
Description:Treatment duration in weeks
description
Type:factor (First/Reference level = Buprenorphine-naloxone stabilization)
Description:Description of the treatment duration
Levels:Buprenorphine-naloxone stabilization, Buprenorphine-naloxone treatment, Post-medication follow-up, Taper, Treatment